As of this week in Montana, any biotech company with an experimental drug has a clear path to selling it to consumers. Companies whose drugs have been through preliminary testing—sometimes in as few as 10 healthy people—can pay $12,500 to apply to a newly established review board for approval. Once its treatment is rubber-stamped, the…
Last week, we hosted EmTech MIT, MIT Technology Review’s annual flagship conference in Cambridge, Massachusetts. Over the course of three days of main-stage sessions, I learned about innovations in AI, biotech, and robotics. But as you might imagine, some of this climate reporter’s favorite moments came in the climate sessions. I was listening especially closely…
In a business built on belief, the founders who communicate clearly, deliver reliably and treat every dollar with respect earn trust that outlasts any funding round.